Insecticides (India) Limited — Investor Meet, 17-08-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Insecticides (India) Ltd. (IIL) reported Q1 FY27 revenue down 12% to INR612 Cr, impacted by delayed monsoon. Gross margin improved to 31.6%, though EBITDA and PAT margins compressed. Premium products now contribute 64% to B2C sales. Management expects demand recovery from Q2. Sotanala formulation plant is due April-May next year, technicals by Diwali. Total Sotanala investment is INR200 Cr, with INR70 Cr already invested. Q1 saw 13% volume degrowth. New launches Granuvia and Spinoace project INR25 Cr net sales this fiscal. IIL aims for sustainable growth, efficiency, and improved capital efficiency as investments conclude.